See more : Cipia Vision Ltd (CPIA.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Acrux Limited (ARUXF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acrux Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- CB Financial Services, Inc. (CBFV) Income Statement Analysis – Financial Results
- Muthoot Microfin Limited (MUTHOOTMF.NS) Income Statement Analysis – Financial Results
- CANEX Metals Inc. (NOMNF) Income Statement Analysis – Financial Results
- Sinyi Realty Inc. (9940.TW) Income Statement Analysis – Financial Results
- Metalicity Limited (MCT.AX) Income Statement Analysis – Financial Results
Acrux Limited (ARUXF)
About Acrux Limited
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.09M | 8.43M | 1.72M | 1.34M | 1.25M | 631.00K | 2.69M | 23.32M | 28.01M | 24.62M | 53.37M | 15.55M | 8.80M | 89.60M | 54.90M | 650.00K | 3.84M | 2.90M | 517.00K | 2.71M | 3.26M | 746.31K | 547.45K |
Cost of Revenue | 3.96M | 558.00K | 6.37M | 8.93M | 5.01M | 5.12M | 5.39M | 136.00K | 988.00K | 859.00K | 1.83M | 533.00K | 261.00K | 3.01M | 1.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 1.13M | 7.87M | -4.65M | -7.59M | -3.76M | -4.49M | -2.70M | 23.19M | 27.02M | 23.76M | 51.54M | 15.02M | 8.54M | 86.60M | 52.99M | 650.00K | 3.84M | 2.90M | 517.00K | 2.71M | 3.26M | 746.31K | 547.45K |
Gross Profit Ratio | 22.27% | 93.38% | -270.62% | -567.76% | -300.00% | -711.89% | -100.52% | 99.42% | 96.47% | 96.51% | 96.58% | 96.57% | 97.03% | 96.64% | 96.52% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 2.42M | 3.81M | 6.37M | 8.93M | 5.01M | 5.12M | 4.03M | 3.24M | 1.43M | 705.00K | 756.00K | 752.00K | 905.00K | 1.03M | 1.02M | 1.58M | 3.74M | 5.90M | 4.76M | 4.24M | 3.11M | 4.42M | 3.24M |
General & Administrative | 5.77M | 5.77M | 6.08M | 6.36M | 5.94M | 6.21M | 5.79M | 5.05M | 4.56M | 4.29M | 3.97M | 2.95M | 3.22M | 3.25M | 2.89M | 4.58M | 5.03M | 4.72M | 4.96M | 3.98M | 3.03M | 2.05M | 1.08M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.21M | 632.00K | 716.00K | 324.00K | 471.00K | 341.00K | 601.00K | 873.00K | 92.00K | 128.00K | 148.00K | 493.00K | 280.47K | 53.37K | 0.00 | 0.00 |
SG&A | 5.77M | 5.77M | 6.08M | 6.36M | 5.94M | 6.21M | 5.79M | 5.05M | 4.56M | 4.29M | 3.97M | 2.95M | 3.22M | 3.25M | 2.89M | 4.67M | 5.15M | 4.87M | 5.45M | 4.26M | 3.08M | 2.05M | 1.08M |
Other Expenses | -7.06M | 3.38M | 3.37M | 3.79M | 2.48M | 4.08M | -168.00K | -593.00K | -1.76M | -671.00K | -3.05M | -365.00K | 0.00 | -4.75M | -1.75M | 1.28M | 222.00K | 902.00K | 1.03M | 730.27K | 28.37K | -617.78K | 282.95K |
Operating Expenses | 1.13M | 11.26M | 14.69M | 17.59M | 13.33M | 13.62M | 13.67M | 12.76M | 8.71M | 7.70M | 6.94M | 6.09M | 5.53M | 6.29M | 5.49M | 11.22M | 11.40M | 12.74M | 12.81M | 10.81M | 7.94M | 6.72M | 4.38M |
Cost & Expenses | 5.09M | 11.82M | 14.69M | 17.59M | 13.33M | 13.62M | 13.67M | 12.89M | 9.69M | 8.56M | 8.76M | 6.62M | 5.79M | 9.30M | 7.41M | 11.22M | 11.40M | 12.74M | 12.81M | 10.81M | 7.94M | 6.72M | 4.38M |
Interest Income | 134.00K | 122.00K | 18.00K | 34.00K | 216.00K | 579.00K | 671.00K | 613.00K | 548.00K | 564.00K | 470.00K | 943.00K | 1.65M | 3.70M | 1.03M | 1.58M | 2.55M | 1.08M | 1.32M | 1.33M | 418.02K | 637.77K | 408.80K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 179.00 | 233.00 | 7.43K | 0.00 |
Depreciation & Amortization | 510.00K | 595.00K | 660.00K | 665.00K | 708.00K | 426.00K | 618.00K | 1.56M | 1.49M | 1.43M | 1.41M | 1.42M | 349.00K | 246.00K | 475.00K | 599.00K | 486.00K | 519.00K | 510.00K | 420.51K | 282.18K | 243.27K | 62.89K |
EBITDA | -8.07M | -2.81M | -12.31M | -15.59M | -11.37M | -12.56M | -9.33M | 22.81M | 20.80M | 18.34M | 47.85M | 10.89M | 3.62M | 83.56M | 49.89M | -9.98M | -6.42M | -9.33M | -11.78M | -5.62M | -3.95M | -5.71M | -3.77M |
EBITDA Ratio | -158.42% | -29.35% | -715.88% | -1,165.74% | -907.34% | -1,991.13% | -175.51% | 97.79% | 74.25% | 74.50% | 89.65% | 70.01% | 41.13% | 93.25% | 90.86% | -1,534.62% | -184.07% | -321.92% | -2,279.11% | -207.42% | -120.99% | -764.58% | -689.32% |
Operating Income | -8.58M | -3.07M | -12.97M | -16.25M | -12.08M | -12.99M | -5.33M | 21.25M | 19.30M | 16.91M | 46.43M | 9.46M | 3.27M | 83.31M | 49.41M | -10.57M | -7.56M | -9.85M | -12.29M | -6.04M | -4.23M | -5.95M | -3.84M |
Operating Income Ratio | -168.43% | -36.41% | -754.28% | -1,215.48% | -963.85% | -2,058.64% | -198.51% | 91.10% | 68.92% | 68.71% | 87.00% | 60.86% | 37.16% | 92.98% | 90.00% | -1,626.77% | -196.72% | -339.83% | -2,377.76% | -222.93% | -129.64% | -797.17% | -700.81% |
Total Other Income/Expenses | 3.01M | 3.18M | 3.38M | 3.82M | 2.69M | 4.66M | -6.57M | -11.14M | -772.00K | 1.00K | -1.24M | 132.00K | 1.65M | -800.00K | -241.00K | 2.86M | 2.12M | 1.98M | 2.35M | 2.06M | 446.16K | 12.56K | 691.75K |
Income Before Tax | -5.57M | -212.00K | -9.58M | -12.43M | -9.39M | -8.34M | -16.13M | -94.00K | 18.09M | 16.81M | 43.86M | 10.04M | 4.92M | 82.51M | 49.17M | -7.71M | -4.78M | -7.86M | -9.94M | -6.04M | -4.23M | -5.96M | -3.14M |
Income Before Tax Ratio | -109.37% | -2.52% | -557.42% | -929.84% | -749.00% | -1,320.92% | -600.11% | -0.40% | 64.59% | 68.27% | 82.18% | 64.58% | 55.88% | 92.09% | 89.56% | -1,186.62% | -124.47% | -271.35% | -1,922.44% | -222.94% | -129.64% | -798.17% | -574.45% |
Income Tax Expense | 232.00K | 552.00K | 252.00K | 197.00K | 86.00K | -10.00K | -1.94M | 149.00K | 5.11M | 5.68M | 15.89M | 3.12M | -2.48M | 25.36M | 2.62M | 3.00K | 245.00K | -1.08M | -1.32M | -6.04M | -4.23M | -5.96M | -3.14M |
Net Income | -5.80M | -764.00K | -9.83M | -12.63M | -9.47M | -8.33M | -14.18M | -243.00K | 12.98M | 11.13M | 27.97M | 6.93M | 7.39M | 57.15M | 46.55M | -7.72M | -5.03M | -7.86M | -9.94M | 23.97K | -2.99K | -10.02K | -3.14M |
Net Income Ratio | -113.93% | -9.06% | -572.08% | -944.58% | -755.87% | -1,319.33% | -527.80% | -1.04% | 46.35% | 45.21% | 52.41% | 44.54% | 84.02% | 63.78% | 84.79% | -1,187.08% | -130.85% | -271.32% | -1,922.63% | 0.88% | -0.09% | -1.34% | -574.45% |
EPS | -0.02 | 0.00 | -0.03 | -0.06 | -0.06 | -0.05 | -0.09 | 0.00 | 0.08 | 0.07 | 0.17 | 0.04 | 0.04 | 0.35 | 0.29 | -0.05 | -0.03 | -0.06 | -0.07 | 0.00 | 0.00 | 0.00 | -0.03 |
EPS Diluted | -0.02 | 0.00 | -0.03 | -0.06 | -0.06 | -0.05 | -0.09 | 0.00 | 0.08 | 0.07 | 0.17 | 0.04 | 0.04 | 0.35 | 0.29 | -0.05 | -0.03 | -0.06 | -0.07 | 0.00 | 0.00 | 0.00 | -0.03 |
Weighted Avg Shares Out | 289.50M | 286.46M | 283.88M | 219.73M | 167.77M | 166.58M | 166.46M | 162.00M | 166.52M | 166.52M | 166.52M | 166.50M | 166.50M | 164.54M | 160.10M | 159.38M | 157.28M | 138.32M | 134.03M | 124.33M | 100.85M | 99.04M | 99.04M |
Weighted Avg Shares Out (Dil) | 289.50M | 286.46M | 283.88M | 219.73M | 167.77M | 166.58M | 166.52M | 166.52M | 166.52M | 166.52M | 166.52M | 166.50M | 166.50M | 165.60M | 162.21M | 159.38M | 157.28M | 138.32M | 134.03M | 124.33M | 100.85M | 99.04M | 99.04M |
Source: https://incomestatements.info
Category: Stock Reports